1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Legacy Male Fertility Research Award is sponsored by Legacy, in partnership with The American Society of Reproductive Medicine (ASRM) Research Institute. This grant supports innovative research projects that provide insights into the causes of male factor infertility, such as the effect of chemicals and the environment on men's sperm quality. The project should lead to a published manuscript.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Legacy Male Fertility Research Award - ASRM Research Institute Skip auxiliary navigation (Press Enter). Legacy Male Fertility Research Award Legacy Male Fertility Research Award Legacy, in partnership with The American Society of Reproductive Medicine (ASRM) Research Institute, invites submission of applications for its male fertility research grant.
The purpose of this grant is to support innovative research projects that provide insights into causes of male factor infertility, for example the effect of chemicals and our environment on men's sperm quality. The applicant must demonstrate a strong career goal within the field of Reproductive Medicine and must be dedicated to the advancement of male reproductive health research and semen studies.
The scope of the study could be clinical, basic science, or public health related but cannot include animal studies. Funds may be used for support of a new or ongoing research or clinical investigation project. Applicants must be actively working in areas related to reproductive medicine in the United States.
The principal investigator (PI) must: Have a doctorate degree (MD, MD/PhD, PhD, DO, ScD or equivalent) and have sufficient expertise, commitment of effort, organizational structure, and operational effectiveness to successfully implement the plan for the proposed research. Be an independent investigator serving as a full-time clinician/physician scientist (academic, private practice, other non-profit or for-profit organizations).
Fellows and postdoctoral trainees may apply but must complete the project prior to their program completion. Award(s) to be distributed at a maximum of $50,000 for a ONE (1) year study period. An application must include the following information in order as described below.
Additionally, all letters must be included in your application package and cannot be sent separately or post application deadline. Please note: Letters outside the required department head or program chair letters are not required but you may submit up to 2 additional letters of support should you choose.
Title of the project (not to exceed 200 characters including spaces) Applicant’s name and credentials Applicant’s department affiliation & sponsoring institution Contact information including mailing address, telephone number and email IF YOU ARE A FELLOW : Research mentor must be named Total funding amount requested IF YOU ARE A PRACTICING PHYSICIAN : Chairman/Division Chief letter (no more than two pages) acknowledging the applicant’s project and grant proposal, endorsing the applicant’s research, and confirming the institution’s commitment to provide time and support to the applicant.
IF YOU ARE A FELLOW : A letter of support must be provided by your research mentor confirming the institution’s and/or practice’s commitment to provide time and support to the applicant. Applicant letter must also state career goals and plans for achieving these goals, including a lay statement of 2-3 sentences describing the relevance of the proposed research.
Abstract (One page maximum) Scientific Abstract (500 words) describing the research proposal including the potential immediate impact of the anticipated results on the practice of reproductive medicine Lay-person Abstract (200 words) describing the project in general terms Specific Aims of the research proposal presented in NIH format– (One page maximum) A research proposal should include the following sections (no more than three pages) Background and Significance Innovation and Potential Impact Research Plan (methodology and statistical analysis plan must be clearly described) Timeline for project start up, implementation, and completion References/citations are required but do not count against the total number of pages for the application.
You may also include them as an appendix. Each Biosketch should include a specific description of the role of each investigator in the proposed project and should not exceed FIVE pages (including the current funding) A detailed yearly and cumulative budget and budget justification for the project. Conference travel and/or registration expenses up to $1000 to present results related to this award.
Funds are available for project expenses, technical assistance, patient expenses, research supplies and durable laboratory equipment (under $2000) used for the purposes of this project, analysis software, national registries, survey licenses, etc. Indirect costs (institutional overhead) will NOT be supported. Funds may NOT be used towards degree seeking courses, cost of routine clinical care, or research team salary and/or benefits.
The proposal must be typed in Calibri 12 pt. type with page margins no less than . 5 inches and no more than 1 inch Pagination should be included at the bottom of each page (excluding the Title page) The entire application must be submitted as ONE PDF FILE to research@asrm.
org , by 4pm EST on December 1, 2023 . SUBJECT LINE : LEGACY MALE FERTILITY GRANT PROPOSAL Human use must be approved by the Institutional Review Board or Institutional Animal Care and Use Committee, or their equivalent and documented before funds are released, but pre-approval is not required for application.
It is required that any research involving human embryos will comply with applicable federal and state laws and will be in line with the ASRM’s guidance document on the ethics of human embryo research. No research will proceed without all relevant Institutional Board(s) and Committee(s) reviews and approval.
An ASRM Research Institute Grant Review Group (GRG) in collaboration with an appointed designee from Legacy will review the proposals and awardees determined. To avoid a potential conflict of interest, members of the GRG will recuse themselves from review of any proposal that involves their institutions of employment. Award notifications will be made in February 2024 and funding will be dispersed March 2024.
The project will have the following objectives: Furtherance of ASRM’s mission to advance the science of reproductive medicine. Furtherance of Legacy’s mission to support innovative research projects that provide insights into causes of male factor infertility: The project should lead to a published manuscript that would add to the body of research and provide additional high-quality scientific evidence in the field of male fertility.
The project will have the following deliverables: A published manuscript in a peer-reviewed, high-impact scientific journal that will contribute to the advancement of the field of male factor infertility and sperm studies. Presentation of grant recipients’ research findings at an ASRM Congress within two years of receiving the award. Annual progress and financial reports are required and should be sent to research@asrm.
org . ASRM Research Institute will review and provide a confirmation of progress report acceptance via email. Continued funding will depend on demonstrated progress and productivity as well as compliance with progress report timelines and any regulatory requirements.
A final progress and financial report is required and should be submitted to ASRM within 90 days of project completion .
PUBLICATION, PUBLICITY, AND CO-BRANDING Publications, abstracts, manuscripts and/or presentations at scientific conferences or meetings based on results from the funded project must acknowledge Legacy and ASRM using the following language: “Funded in part by a grant from Legacy in partnership with the American Society for Reproductive Medicine.
” Results and research findings must be presented at the ASRM Congress within two years of receiving the award and copy of any published works should be sent to Legacy and ASRM Research Institute.
According to the current listing, eligibility includes: Applicants must demonstrate a strong career goal within the field of Reproductive Medicine and be dedicated to the advancement of male reproductive health research and semen studies. Confirm the full requirements in the official notice before applying.
Legacy Male Fertility Research Award is funded by Legacy, in partnership with The American Society of Reproductive Medicine (ASRM) Research Institute. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleNEA's FY2027 Partnership Agreement Grants (2027NEA04PA) put $59 million into 56 state arts agencies with a September 29, 2026 deadline. No individual arts nonprofit can apply. But this is the channel through which most NEA dollars actually reach small organizations — and the supplanting rule and 1-to-1 state cost share determine how much reaches yours.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read article